GT Biopharma(DE:OXI)
€119.250.00 (0.00%)
DE:OXI
GT Biopharma financials statements
€119.25
At close:0.00 (0.00%)
GT Biopharma (OXI) Financial Statements
0 Followers
GT Biopharma Financial Overview
GT Biopharma's market cap is currently $7.36M. The company's EPS TTM is $-104.00; its P/E ratio is -0.04; GT Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -12.42M | $ -14.36M | $ -13.58M | $ -21.26M | $ -57.52M |
| EBITDA | $ -28.23M | $ -13.16M | $ 5.98M | $ -20.96M | $ -57.48M |
| Net Income | $ -28.35M | $ -13.16M | $ -7.60M | $ -20.88M | $ -58.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.81M | $ 3.95M | $ 13.97M | $ 16.51M | $ 31.98M |
| Total Assets | $ 8.11M | $ 4.23M | $ 14.11M | $ 16.74M | $ 32.17M |
| Total Debt | $ 0.00 | $ 0.00 | $ 58.00K | $ 174.00K | $ 31.00K |
| Net Debt | $ -6.81M | $ -3.95M | $ -1.02M | $ -5.50M | $ -8.94M |
| Total Liabilities | $ 2.32M | $ 5.90M | $ 6.63M | $ 5.00M | $ 10.26M |
| Stockholders' Equity | $ 5.79M | $ -1.67M | $ 7.48M | $ 11.73M | $ 21.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.91M | $ -12.90M | $ -8.85M | $ -15.22M | $ -15.61M |
| Operating Cash Flow | $ -12.91M | $ -12.90M | $ -8.85M | $ -15.22M | $ -15.61M |
| Investing Cash Flow | $ 0.00 | $ 12.89M | $ -2.01M | $ 12.14M | $ -23.04M |
| Financing Cash Flow | $ 15.78M | $ 2.98M | $ 6.27M | $ -224.00K | $ 42.32M |
Currency in USD
